Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. [electronic resource] by
- Chau, M M
- Kong, D C M
- van Hal, S J
- Urbancic, K
- Trubiano, J A
- Cassumbhoy, M
- Wilkes, J
- Cooper, C M
- Roberts, J A
- Marriott, D J E
- Worth, L J
Producer: 20150825
In:
Internal medicine journal vol. 44
Availability: No items available.
|
|
|
18.
|
Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics. [electronic resource] by
- Wu, D B C
- Chaiyakunapruk, N
- Pratoomsoot, C
- Lee, K K C
- Chong, H Y
- Nelson, R E
- Smith, P F
- Kirkpatrick, C M
- Kamal, M A
- Nieforth, K
- Dall, G
- Toovey, S
- Kong, D C M
- Kamauu, A
- Rayner, C R
Producer: 20181120
In:
Epidemiology and infection vol. 146
Availability: No items available.
|